专题：Prostate Cancer Treatment and Research

This cluster of papers represents a comprehensive exploration of advancements in prostate cancer research, covering topics such as androgen receptor signaling, genomic profiling, hormone therapy, immunotherapy, genetic mutations, clinical trials, biomarkers, and molecular biology. The papers discuss the molecular determinants of resistance to antiandrogen therapy, the impact of translocations and gene fusions on cancer causation, and the development of second-generation antiandrogens for the treatment of advanced prostate cancer.
最新文献
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

review Full Text OpenAlex

Integrins as Key Mediators of Metastasis

review Full Text OpenAlex

Disulfidptosis-related subtype and prognostic signature in prostate cancer

article Full Text OpenAlex

Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer

article Full Text OpenAlex

PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects

review Full Text OpenAlex

Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities

review Full Text OpenAlex

AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients

article Full Text OpenAlex

Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate

article Full Text OpenAlex

Efficacy of docetaxel addition to next‐generation androgen receptor‐axis‐targeted therapies and androgen deprivation therapy in metastatic hormone‐sensitive prostate cancer: A tumor volume‐specific analysis

article Full Text OpenAlex

Life expectancy in rare histological prostate cancer subtypes

article Full Text OpenAlex

近5年高被引文献
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

article Full Text OpenAlex 2181 FWCI284.4121722

The Influence of Finasteride on the Development of Prostate Cancer

book-chapter Full Text OpenAlex 2085 FWCI65.31576799

Prostate cancer

review Full Text OpenAlex 997 FWCI140.26048044

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

article Full Text OpenAlex 959 FWCI132.47805782

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

article Full Text OpenAlex 770 FWCI157.77183905

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

review Full Text OpenAlex 714 FWCI146.09262499

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

review Full Text OpenAlex 692 FWCI592.62209814

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

article Full Text OpenAlex 667 FWCI136.66729435

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

article Full Text OpenAlex 605 FWCI204.11186627

Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019

article Full Text OpenAlex 579 FWCI121.09500893